End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
16,000 CZK | +0.25% | +0.13% | +2.43% |
Mar. 26 | Philip Morris CR a.s. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Mar. 18 | Philip Morris CR a.s.(SEP:TABAK) dropped from FTSE All-World Index | CI |
Summary
- On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium and long-term investment perspective.
Strengths
- The company returns high margins, thereby supporting business profitability.
- This company will be of major interest to investors in search of a high dividend stock.
- The opinion of analysts covering the stock has improved over the past four months.
- Over the past twelve months, analysts' opinions have been strongly revised upwards.
- The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.
Weaknesses
- As estimated by analysts, this group is among those businesses with the lowest growth prospects.
- The potential for earnings per share (EPS) growth in the coming years appears limited according to current analyst estimates.
- The sales outlook for the group was lowered in the last twelve months. This change in forecast points out a decline in activity as well as pessimistic analyses of the company.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
- Over the past four months, analysts' average price target has been revised downwards significantly.
Ratings chart - Surperformance
Sector: Tobacco
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+2.43% | 1.87B | - | ||
+2.09% | 148B | B- | ||
+1.55% | 19.56B | A- | ||
+5.69% | 5.39B | B- | ||
+58.65% | 2.08B | - | C+ | |
-7.36% | 1.63B | - | D+ | |
-22.46% | 1.26B | - | B+ | |
-.--% | 657M | - | - | |
+10.90% | 510M | C+ | ||
-16.01% | 451M | - | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
- Stock Market
- Equities
- TABAK Stock
- Ratings Philip Morris CR